Physician Interactions With Industry: Striking the Right Balance

Authors:
Cory L. Anand
Search for other papers by Cory L. Anand in
Current site
Google Scholar
PubMed
Close
 JD
and
Raed A. Dweik
Search for other papers by Raed A. Dweik in
Current site
Google Scholar
PubMed
Close
 MD, MBA
Restricted access

Published online December 29, 2021.

Disclosures: The authors have disclosed that they have no financial interests, arrangements, or affiliations with the manufacturers of any products discussed in this article or their competitors.

Correspondence: Raed A. Dweik, MD, MBA, Innovation Management and Conflict of Interest Program, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195. Email: dweikr@ccf.org
  • Collapse
  • Expand
  • 1.

    Patient Protection and Affordable Care Act. Pub L No. 111–148, 124 Stat 119–1025 (2010).

    • PubMed
    • Export Citation
  • 2.

    Chimonas S, Rozario NM, Rothman DJ. Show us the money: lessons in transparency from state pharmaceutical marketing disclosure laws. Health Serv Res 2010;45:98114.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Rose SL, Sanghani RM, Schmidt C, et al. Gender differences in physicians’ financial ties to industry: a study of national disclosure data. PLoS One 2015;10:e0129197.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Tringale KR, Marshall D, Mackey TK, et al. Types and distribution of payments from industry to physicians in 2015. JAMA 2017;317:17741784.

  • 5.

    Inoue K, Blumenthal DM, Elashoff D, et al. Association between physician characteristics and payments from industry in 2015–2017: observational study. BMJ Open 2019;9:e031010.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Perlis RH, Perlis CS. Physician payments from industry are associated with greater Medicare Part D prescribing costs. PLoS One 2016;11:e0155474.

  • 7.

    Rhee TG, Ross JS. Association between industry payments to physicians and gabapentinoid prescribing. JAMA Intern Med 2019;179:14251428.

  • 8.

    Kaestner V, Edmiston JB, Prasad V. The relation between publication rate and financial conflict of interest among physician authors of high-impact oncology publications: an observational study. CMAJ Open 2018;6:E5762.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Fugh-Berman A, McDonald CP, Bell AM, et al. Promotional tone in reviews of menopausal hormone therapy after the Women’s Health Initiative: an analysis of published articles. PLoS Med 2011;8:e1000425.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Rahman M, Trivedi N, Bach P, Mitchell A. Increasing financial payments from industry to medical oncologists in the United States, 2014–2017 [published online December 28, 2021]. J Natl Compr Cancer Netw, doi: 10.6004/jnccn.2021.7024

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11.

    Tokar D. Health-care industry faces greater scrutiny around payments to doctors to promote products. Wall Street Journal. December 3, 2020. Accessed September 10, 2021. Available at: https://www.wsj.com/articles/health-care-industry-faces-greater-scrutiny-around-payments-to-doctors-to-promote-products-11606991402

    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 636 332 86
PDF Downloads 212 52 2
EPUB Downloads 0 0 0